News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,900 Results
Type
Article (41732)
Company Profile (266)
Press Release (687886)
Multimedia
Podcasts (90)
Webinars (20)
Section
Business (204970)
Career Advice (2031)
Deals (35585)
Drug Delivery (128)
Drug Development (81647)
Employer Resources (173)
FDA (16512)
Job Trends (14997)
News (347054)
Policy (32792)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2604)
Accelerated approval (45)
Adcomms (26)
Allergies (170)
Alliances (49648)
ALS (203)
Alzheimer's disease (1777)
Antibody-drug conjugate (ADC) (428)
Approvals (16872)
Artificial intelligence (635)
Autoimmune disease (256)
Automation (52)
Bankruptcy (362)
Best Places to Work (11656)
BIOSECURE Act (20)
Biosimilars (217)
Biotechnology (176)
Bladder cancer (184)
Brain cancer (71)
Breast cancer (725)
Cancer (5666)
Cardiovascular disease (455)
Career advice (1721)
Career pathing (41)
CAR-T (317)
CDC (54)
Celiac Disease (3)
Cell therapy (847)
Cervical cancer (46)
Clinical research (70641)
Collaboration (2011)
Company closure (5)
Compensation (1332)
Complete response letters (77)
COVID-19 (2806)
CRISPR (105)
C-suite (1068)
Cystic fibrosis (150)
Data (7544)
Decentralized trials (3)
Denatured (27)
Depression (157)
Dermatology (76)
Diabetes (575)
Diagnostics (6914)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (309)
Drug pricing (199)
Drug shortages (31)
Duchenne muscular dystrophy (274)
Earnings (91484)
Editorial (64)
Employer branding (21)
Employer resources (152)
Events (119157)
Executive appointments (1063)
FDA (20127)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1680)
Gene editing (226)
Generative AI (54)
Gene therapy (687)
GLP-1 (1039)
Government (4738)
Grass and pollen (7)
Guidances (403)
Healthcare (19020)
HIV (77)
Huntington's disease (55)
IgA nephropathy (93)
Immunology and inflammation (281)
Immuno-oncology (86)
Indications (176)
Infectious disease (3144)
Inflammatory bowel disease (205)
Inflation Reduction Act (14)
Influenza (140)
Intellectual property (284)
Interviews (318)
IPO (16664)
IRA (50)
Job creations (3649)
Job search strategy (1430)
JPM (58)
Kidney cancer (18)
Labor market (96)
Layoffs (558)
Leadership (37)
Legal (7958)
Liver cancer (99)
Longevity (32)
Lung cancer (753)
Lymphoma (421)
Machine learning (58)
Management (59)
Manufacturing (993)
MASH (179)
Medical device (13918)
Medtech (14016)
Mergers & acquisitions (20138)
Metabolic disorders (1461)
mRNA (198)
Multiple sclerosis (183)
NASH (17)
Neurodegenerative disease (399)
Neuropsychiatric disorders (103)
Neuroscience (3245)
Neurotech (1)
NextGen: Class of 2026 (6525)
Non-profit (4532)
Now hiring (76)
Obesity (683)
Opinion (286)
Ovarian cancer (209)
Pain (246)
Pancreatic cancer (288)
Parkinson's disease (351)
Partnered (33)
Patents (582)
Patient recruitment (644)
Peanut (61)
People (59503)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22029)
Phase 2 (31112)
Phase 3 (23157)
Pipeline (7922)
Policy (310)
Postmarket research (2570)
Preclinical (9385)
Press Release (64)
Prostate cancer (290)
Psychedelics (52)
Radiopharmaceuticals (317)
Rare diseases (1034)
Real estate (5970)
Recruiting (70)
Regulatory (25277)
Reports (55)
Research institute (2427)
Resumes & cover letters (353)
Rett syndrome (36)
RNA editing (20)
RSV (88)
Schizophrenia (176)
Series A (280)
Series B (208)
Service/supplier (11)
Sickle cell disease (109)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (48)
Startups (3640)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (61)
Vaccines (1111)
Venture capital (103)
Weight loss (441)
Women's health (120)
Worklife (20)
Date
Last 7 days (759)
Last 30 days (2627)
Last 365 days (30057)
2026 (10609)
2025 (30200)
2024 (35250)
2023 (40114)
2022 (51247)
2021 (55816)
2020 (54129)
2019 (46589)
2018 (35069)
2017 (32155)
2016 (31537)
2015 (37581)
2014 (31362)
2013 (26393)
2012 (28627)
2011 (29319)
2010 (27380)
Location
Africa (742)
Alabama (91)
Alaska (7)
Arizona (342)
Arkansas (14)
Asia (39662)
Australia (6497)
California (12815)
Canada (3670)
China (1299)
Colorado (549)
Connecticut (554)
Delaware (390)
Europe (85892)
Florida (1923)
Georgia (411)
Hawaii (3)
Idaho (62)
Illinois (1025)
India (88)
Indiana (585)
Iowa (23)
Japan (514)
Kansas (129)
Kentucky (50)
Louisiana (39)
Maine (75)
Maryland (1541)
Massachusetts (9130)
Michigan (354)
Minnesota (696)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (138)
New Hampshire (84)
New Jersey (3393)
New Mexico (28)
New York (3366)
North Carolina (1628)
North Dakota (8)
Northern California (6393)
Ohio (381)
Oklahoma (23)
Oregon (41)
Pennsylvania (2581)
Puerto Rico (28)
Rhode Island (50)
South America (1113)
South Carolina (85)
South Dakota (2)
Southern California (5044)
Tennessee (206)
Texas (2026)
United States (45293)
Utah (382)
Vermont (1)
Virginia (306)
Washington D.C. (80)
Washington State (1029)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
729,900 Results for "varian inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Varian TrueBeam Receives FDA Clearance for Low-Dose Radiotherapy for Adults with Medically Refractory Osteoarthritis
March 19, 2026
·
5 min read
Press Releases
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025
·
13 min read
Press Releases
Varian Elevates Halcyon Platform by Redefining the Patient Experience
September 28, 2025
·
4 min read
Press Releases
Sainte Catherine, Institut du Cancer Avignon-Provence (ICAP), Becomes the First Center in Europe to Implement the Varian Latest Halcyon Advancements with Identify integration, PerfectKinetix Dynamic Couch and HyperSight for Personalized Radiotherapy
December 10, 2025
·
4 min read
Press Releases
Varian Completes Enrollment and Treatment in FAST-02 Clinical Trial of Flash Therapy in Treating Thoracic Bone Metastases
August 26, 2025
·
4 min read
Press Releases
Icon Group and Varian Expand Global Partnership to Deliver Advanced Cancer Technology Across the UK
June 26, 2025
·
5 min read
RayCare 2024A interoperable with Varian TrueBeam
RaySearch Laboratories AB is proud to announce that the oncology information system RayCare®* 2024A has been certified to be interoperable with Varian TrueBeam® linear accelerators, version 3.0.
May 16, 2024
·
2 min read
Press Releases
Agreement Between Varian and Embolx Paves the Way for Advanced Image-Guided Therapies for Cancer
March 31, 2025
·
3 min read
Biotech Bay
Varian Receives FDA 510(k) Clearance for TrueBeam and Edge Radiotherapy Systems Featuring HyperSight Imaging Solution
Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for TrueBeam and Edge radiotherapy systems featuring HyperSight imaging solution.
February 29, 2024
·
4 min read
Press Releases
Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results
April 14, 2026
·
2 min read
1 of 72,990
Next
